drugIndia
Cart
Metsmall GV 1 Tablet SR

Metsmall GV 1 Tablet SR

Glimepiride (1mg) + Voglibose (0.2mg) + Metformin (500mg)

Dr Reddy's Laboratories Ltd
Anti-Diabetic
100.50125.6320% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 69%
Best Alternative100% Match

Glimison-VM 1 Tablet SR

Unison Pharmaceuticals Pvt Ltd

Voglibose 0.2mg
Glimison-VM 1 Tablet SR

Pack Size

1 units

Price

31.6020% off
Glimison-VM 1 Tablet SR is 100% same as Metsmall GV 1 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹69

that's 69% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
100.5020% OFF
125.63

About This Medicine

Product description & overview

Metsmall GV 1 Tablet SR: Comprehensive Glucose Control

Metsmall GV 1 Tablet SR is a triple-action formulation containing Glimepiride, Metformin, and Voglibose to help manage Type 2 Diabetes. This unique combination provides comprehensive glucose control by targeting three crucial mechanisms:

• Glimepiride: A sulfonylurea that stimulates insulin secretion from the pancreas.

• Metformin: A biguanide that improves insulin sensitivity in the body's cells, helping them use glucose more efficiently.

• Voglibose: An alpha-glucosidase inhibitor that inhibits glucose absorption in the gut, further reducing postprandial blood sugar spikes.

Each tablet contains a precise blend of 1mg Glimepiride, 500mg Metformin, and 0.2mg Voglibose to create a balanced treatment strategy for individuals with Type 2 Diabetes.

Please Note: This medicine should be taken under the guidance of your healthcare professional. Consult with your doctor before starting or discontinuing any medication.

Active composition

Glimepiride 1 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
1 mg

All Active Ingredients

Glimepiride1 mg
Voglibose0.2 mg
Metformin500 mg

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Metsmall GV 1 Tablet SR.

High Risk

Pregnancy

Metsmall GV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Metsmall GV 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Metsmall GV 1 Tablet SR may be needed. Please consult your doctor. Metsmall GV 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Metsmall GV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Metsmall GV 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Metsmall GV 1 Tablet SR is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Metsmall GV 1 Tablet SR

Products matching your search